Reprint | The 6th International Symposium on Human Pluripotent Stem Cell Research and Treatment (PSConf 2026) and the first academic conference of the Asian Stem Cell and Regenerative Medicine Alliance (first round of notice)

Release time:2026/5/12
picture
1

Meeting information

In order to strengthen international exchanges and cooperation in the field of stem cell research and therapeutic transformation, and promote the transformation of cutting-edge results in stem cells and regenerative medicine into practical applications, The 6th International Symposium on Human Pluripotent Stem Cell Research and Treatment (Pluripotent Stem Cell Conference 2026, PSConf 2026) and the first academic conference of the Asian Alliance of Stem Cells and Regenerative Medicine (AASCRM Inaugural Summit), Will It will be held simultaneously at the Beijing International Convention Center from October 9 to 11, 2026.

PSConf–AASCRM 2026 conference will be held in “Pathways to Organ Regeneration: State of the art in underpinning science and technology” focus on the theme Three main lines: cutting-edge scientific research, alliance strategic dialogue and international organization cooperation . The meeting will Establish multiple academic forums focusing on the basic science of organ regeneration, stem cell system characterization, automated large-scale expansion and clinical transformation, etc. system Explore the key technological breakthroughs and transformation paths of human pluripotent stem cells and their derivative drugs from research and development to application. At the level of alliances and international collaboration, the meeting will simultaneously promote high-level consultations on two major platforms: First, the ISCA closed-door strategic meeting will conduct dialogue around the international stem cell research collaboration framework. ISSCR, ISCT, ISCBI, ISCI, hPSCreg, ISFO and other international organizations Representatives will conduct a dialogue around the international stem cell research and development collaboration framework; The second is the AASCRM closed-door strategic meeting, when chairmen and representatives of stem cell societies from member countries such as China, Japan, South Korea, Singapore and Australia will gather in Beijing. Conduct in-depth consultations on topics such as alliance cooperation framework, joint research, policy coordination and education promotion, Provide substantive support for alliance strategic dialogue. In addition, the Asian Stem Cell Alliance Leadership Forum and Young Scientists Forum will bring together heads of member societies and regional outstanding young scholars to build a cooperation network and talent echelon. This conference will comprehensively It presents the entire chain of innovation progress from basic frontiers to translational applications, and is committed to building a high-end academic and strategic collaboration platform linking the Asian and global stem cell fields.

This conference is hosted by the Beijing Institute of Stem Cell and Regenerative Medicine (BISCRM), the Institute of Zoology of the Chinese Academy of Sciences (IOZ-CAS), the International Stem Cell Alliance (ISCA), the Asian Alliance of Stem Cells and Regenerative Medicine (AASCRM), the Stem Cell Biology Branch of the Chinese Society of Cell Biology (CSSCR), the Beijing Keqiao Charity Foundation (KF), and the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform (CA SCRM), the International Stem Cell Organization (ISCF), the National Stem Cell Resource Bank (NSCRC), and is hosted by Beijing Zuixin Science and Technology Co., Ltd., and joins hands with the European Commission European Human Pluripotent Stem Cell Registry (hPSCreg), the International Stem Cell Bank Action Plan (ISCBI), the International Stem Cell Initiative (ISCI) and other international organizations to jointly present an open, cutting-edge, cross-regional academic event.

The conference will build an efficient and professional communication platform for global scientific researchers, industry representatives and policy makers, focusing on the latest achievements and application prospects of transforming human pluripotent stem cell research into health solutions. This is not only an academic feast for the exchange of ideas and knowledge sharing, but also an important opportunity to expand international horizons, stimulate cross-border innovation, and jointly shape the future of stem cells and regenerative medicine.

2

meeting time

International Symposium on Human Pluripotent Stem Cell Research and Treatment

October 9-10, 2026

The first academic conference of the Asian Stem Cell and Regenerative Medicine Alliance

October 11, 2026

3

Meeting location and size

Place: Beijing International Convention Center (No. 8, Beichen East Road, Chaoyang District)

scale: 800 people

4

Overview of the public meeting schedule

1.jpg
2.jpg
5

Investment content

Standard booth:

RMB 50,000 (limit 16 people, see venue map) 

Exhibitor rights:

(1) Configure a display stand (3 meters × 3 meters) on site and arrange it yourself for corporate promotion.

(2) The company name or logo will be published on the home page of the conference website, and the company name and contact information will be listed in the conference manual, etc.

(3) Two delegates will receive free registration for the conference.

Note: Choose booths in order of payment by the company.

Payment method

Bank transfer: Beijing Zuixin Science and Technology Co., Ltd.

Account number: 0200066209200079910

Account opening bank: Industrial and Commercial Bank of China Co., Ltd. Beijing Huairou Science City Branch

*Note: Please note "PSConf2026" when remitting. After payment, please send the remittance voucher and payer information to mengxiuying@biscrm.ac.cn for verification. The conference team will send an email confirmation within 3 days after receiving payment.

Contact information

Conference Academic Secretary: psconf@biscrm.ac.cn 

Exhibitor contact: Zou Yichen 13674227087

Venue and exhibition hall map

picture